Please assess the completion status of the following clinical trial:

Trial Title: Does Perioperative Goal Directed Therapy Using Flotrac Improve Outcomes in Esophagectomy Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients 18 years of age or older~* Patients undergoing primary resection of esophageal cancer and resultant esophagectomy.~Exclusion Criteria:~* Patients \< 55kg or \> 140 kg, based on literature regarding accuracy of FloTrac.~* Patients with sustained preoperative dysrhythmias, based on literature regarding accuracy of FloTrac (atrial flutter and/or atrial fibrillation).~* Patients with diagnosed NYHA class III-IV failure or documented EF \< 30%~* Patients who are unable/unwilling to consent for study procedures

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Goal Directed Therapy (Type: ACTIVE_COMPARATOR): In this arm patient will have the FloTrac monitor and a Goal Directed Therapy algorithm will be used to manage blood pressures.
- Usual Care (Type: NO_INTERVENTION): Standard of care will be used to manage blood pressures.

Based on this trial design, predict the completion outcome and termination type (if applicable).